NEW YORK (GenomeWeb News) – The Johannes Gutenberg University Mainz will receive €50 million ($65.4 million) over the next 10 years from the Boehringer Ingelheim Foundation to fund its life sciences activities, the university said on Friday.

The funding will go toward efforts to consolidate JGU's biology program around its Institute of Molecular Biology.

The IMB was established with €100 million in funding from the foundation in 2009, and now JGU said plans for this institute to serve as the basis of its biology activities and faculty.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.